Anyone playing this one? FDA accepted their resubmission for pain drug - REMOXY - decision set for JUNE 23. Received a CRL but had a 11-8 positive panel vote.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.